METTL3 and non-small cell lung carcinoma: Similarly, CAFs were reported to enhance the metastatic potential of NSCLC cells through an N6-methyladenosine (m6A) modification-dependent regulatory mechanism, with methyltransferase-like 3 (METTL3) mediating m6A modification in NSCLC cells [480].